This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dong, L. M. Articles by Peters, U. Search for Related Content PubMed PubMed Citation Articles by Dong, L. M. Articles by Peters, U.

Genetic Variation in Calcium-Sensing Receptor and Risk for Colon Cancer

¹ Fred Hutchinson Cancer Research Center and ² University of Washington, Seattle, Washington; ³ Translational Genomics Research Institute, Phoenix, Arizona; ⁴ Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah; and ⁵ Kaiser Permanente Medical Care Program, Oakland, California

Requests for reprints: Ulrike Peters, Program in Cancer Prevention (M4-B402), Fred Hutchinson Cancer Research Center, P.O. Box 19024, Seattle, WA 98109. Phone: 206-667-5000; Fax: 206-667-7850. E-mail: upeters{at}fhcrc.org

Background: Experimental and epidemiologic studies have suggested that high calcium intake is associated with decreased colon cancer risk, yet very limited data are available for candidate genes in the calcium–vitamin D pathway and colon cancer risk. To address this, we evaluated whether calcium-sensing receptor (CASR) single-nucleotide polymorphisms are associated with colon cancer risk. We also examined interactions among CASR, calcium, and vitamin D intake and previously genotyped vitamin D–related genes.

Methods: We conducted a large multicenter population-based case-control study of 1,600 cases and 1,949 controls. Seventeen tagging single-nucleotide polymorphisms for CASR were selected from common single-nucleotide polymorphisms (minor allele frequency, 5%) based on resequencing data. Haplotypes were estimated and evaluated using HaploStats.

Results: We did not observe an association between any CASR genotypes or haplotypes and colon cancer risk overall. However, when stratified by anatomic site, statistically significant associations were seen with risk for proximal colon cancer [rs10934578 TT: odds ratio, 1.35; 95% confidence interval (95% CI), 1.01-1.81; rs12485716 AG/AA: odds ratio, 0.84; 95% CI, 0.71-1.00; rs4678174 CT/CC: odds ratio, 0.83; 95% CI, 0.70-0.98; rs2270916 CC: odds ratio, 0.43; 95% CI, 0.19-0.97]. Concordantly, we observed a suggested association for a CASR haplotype (rs4678174, rs2270916) with risk for proximal colon cancer (global P = 0.08). We did not observe any meaningful gene-environment (calcium and vitamin D) or gene-gene (CYP24A1, CYP27B1, and VDR) interactions with CASR genotypes and colon cancer risk.

Conclusion: Our study does not provide evidence for an overall association between CASR single-nucleotide polymorphisms and colon cancer; however, results suggest a possible role of CASR on proximal colon cancer, and subsite differences are consistent with known calcium biology. Nonetheless, these findings require confirmation. (Cancer Epidemiol Biomarkers Prev 2008;17(10):2755–65)